Andrea Pietrabissa1, Luigi Pugliese2,3, Alessio Vinci1, Andrea Peri1, Francesco Paolo Tinozzi1, Emma Cavazzi1, Eugenia Pellegrino1, Catherine Klersy4. 1. Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy. 2. Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy. luipugliese@gmail.com. 3. Unit of General Surgery 2, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi, 19, 27100, Pavia, Italy. luipugliese@gmail.com. 4. Service of Biometry and Statistics, Research Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Abstract
BACKGROUND: Randomized studies could not demonstrate significant outcome benefit after single-incision laparoscopic cholecystectomy compared to classic four-port laparoscopic cholecystectomy (CLC). The new robotic single-site platform might offer potential benefits on local inflammation and postoperative pain due to its technological advantages. This prospective randomized double-blind trial compared the short-term outcomes between single-incision robotic cholecystectomy (SIRC) and CLC. METHODS:Two groups of 30 eligible patients were randomized for SIRC or CLC. During the first postoperative week, patients and study monitors were blinded to the type of procedure performed by four dressing tapes applied on the abdomen. Pain was assessed at 6 h and on day 1, 7 and 30 after surgery, along with a 1-10 cosmetic score. RESULTS: No significant difference in postoperative pain occurred in the two groups at any time point nor for any of the abdominal sites. Nineteen (63 %) SIRC patients reported early postoperative pain in extra-umbilical sites. Intraoperative complications which might influence postoperative pain, such as minor bleeding and bile spillage, were similar in both groups and no conversions occurred. The cosmetic score 1 month postoperatively was higher for SIRC (p < 0.001). Two SIRC patients had wound infection, one of which developed an incisional hernia. CONCLUSIONS: SIRC does not offer any significant reduction of postoperative pain compared to CLC. SIRC patients unaware of their type of operation still report pain in extra-umbilical sites like after CLC. The cosmetic advantage of SIRC should be balanced against an increased risk of incisional hernias and higher costs. TRIAL REGISTRATION NUMBER: ACTRN12614000119695 ( http://www.anzctr.org.au ).
RCT Entities:
BACKGROUND: Randomized studies could not demonstrate significant outcome benefit after single-incision laparoscopic cholecystectomy compared to classic four-port laparoscopic cholecystectomy (CLC). The new robotic single-site platform might offer potential benefits on local inflammation and postoperative pain due to its technological advantages. This prospective randomized double-blind trial compared the short-term outcomes between single-incision robotic cholecystectomy (SIRC) and CLC. METHODS: Two groups of 30 eligible patients were randomized for SIRC or CLC. During the first postoperative week, patients and study monitors were blinded to the type of procedure performed by four dressing tapes applied on the abdomen. Pain was assessed at 6 h and on day 1, 7 and 30 after surgery, along with a 1-10 cosmetic score. RESULTS: No significant difference in postoperative pain occurred in the two groups at any time point nor for any of the abdominal sites. Nineteen (63 %) SIRC patients reported early postoperative pain in extra-umbilical sites. Intraoperative complications which might influence postoperative pain, such as minor bleeding and bile spillage, were similar in both groups and no conversions occurred. The cosmetic score 1 month postoperatively was higher for SIRC (p < 0.001). Two SIRC patients had wound infection, one of which developed an incisional hernia. CONCLUSIONS: SIRC does not offer any significant reduction of postoperative pain compared to CLC. SIRC patients unaware of their type of operation still report pain in extra-umbilical sites like after CLC. The cosmetic advantage of SIRC should be balanced against an increased risk of incisional hernias and higher costs. TRIAL REGISTRATION NUMBER: ACTRN12614000119695 ( http://www.anzctr.org.au ).
Authors: Jun Ma; Maria A Cassera; Georg O Spaun; Chet W Hammill; Paul D Hansen; Shaghayegh Aliabadi-Wahle Journal: Ann Surg Date: 2011-07 Impact factor: 12.969
Authors: Anthony Michael Gonzalez; Jorge Rafael Rabaza; Charan Donkor; Rey Jesús Romero; Radomir Kosanovic; Juan Carlos Verdeja Journal: Surg Endosc Date: 2013-08-13 Impact factor: 4.584
Authors: Kimberly M Brown; B Todd Moore; G Brent Sorensen; Conrad H Boettger; Fengming Tang; Phil G Jones; Daniel J Margolin Journal: Surg Endosc Date: 2013-03-22 Impact factor: 4.584
Authors: Sidharth Sharma; Raymond Huang; Shirley Hui; Michael C Smith; Paul J Chung; Alexander Schwartzman; Gainosuke Sugiyama Journal: J Robot Surg Date: 2017-11-27
Authors: S Cianci; A Rosati; V Rumolo; S Gueli Alletti; V Gallotta; L C Turco; G Corrado; G Vizzielli; A Fagotti; F Fanfani; G Scambia; S Uccella Journal: World J Surg Date: 2019-10 Impact factor: 3.352
Authors: Brian Ezekian; Zhifei Sun; Mohamed A Adam; Jina Kim; Megan C Turner; Brian F Gilmore; Cecilia T Ong; Christopher R Mantyh; John Migaly Journal: J Gastrointest Surg Date: 2016-03-10 Impact factor: 3.452